Skip to main content

Table 3 Summary of subgroup analysis

From: Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials

Subgroup

CLOSURE Trial

PC Trial

RESPECT Trial

 

Closure

Medical

Closure

Medical

Closure

Medical

Sex (%)

Male

3.4

6.8

NA

NA

1.9

3.7

Female

7.9

7.0

NA

NA

1.7

2.8

Atrial Septal Aneurysm (%)

No

6.2

7.4

1.9

5.7

2.2

2.2

Yes

4.6

6.0

8.5

3.9

1.1

5.3

Age (%)

≤ 45 yr

NA

NA

1.1

6.2

1.7

2.4

> 45 yr

NA

NA

5.3

4.4

1.9

4.1

Cardiovascular index event (%)

Stroke

5.1

5.1

3.0

4.9

NA

NA

TIA or Peripheral Embolism

7.1

11.6

5.1

6.4

NA

NA

Shunt size (%)

None to Moderate

5.7

6.9

NA

NA

2.8

2.5

Substantial

3.5

4.9

NA

NA

0.8

4.3